Valgancyclovir as maintenance therapy for cytomegalovirus retinitis in a lung transplant patient - A case report

T. J. Wang, C. P. Lin, C. M. Yang, L. L K Lin

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The purpose of this article is to report the use of valgancyclovir as maintenance therapy for cytomegalovirus (CMV) retinitis in a lung transplanted patient A 30-year-old woman with underlying pulmonary lymphangioleiomyomatosis received a lung transplant 1 year ago. CMV retinitis developed 4 months later but subsided after intravenous ganciclovir treatment. Unfortunately, the CMV retinitis recurred three times in 1 year while on oral ganciclovir maintenance therapy. To treat the latest relapse, valgancyclovir 900 mg once daily was used as maintenance therapy after intravenous gancyclovir induction. With a 6-month follow-up, the fundoscopic examination revealed old atrophic scar and no active CMV retinits. The patient was able to maintain best-corrected visual acuity of 20/20 in both eyes. In conclusion, Valganciclovir may be used as maintenance therapy in CMV retinitis.

Original languageEnglish
Pages (from-to)2826-2829
Number of pages4
JournalTransplantation Proceedings
Volume36
Issue number9
DOIs
Publication statusPublished - Nov 2004
Externally publishedYes

Fingerprint

Cytomegalovirus Retinitis
Ganciclovir
Transplants
Lung
Lymphangioleiomyomatosis
Therapeutics
Cytomegalovirus
Visual Acuity
Cicatrix
Recurrence

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Valgancyclovir as maintenance therapy for cytomegalovirus retinitis in a lung transplant patient - A case report. / Wang, T. J.; Lin, C. P.; Yang, C. M.; Lin, L. L K.

In: Transplantation Proceedings, Vol. 36, No. 9, 11.2004, p. 2826-2829.

Research output: Contribution to journalArticle

@article{61a7ccdd687c44fa95421c2e9d554e8a,
title = "Valgancyclovir as maintenance therapy for cytomegalovirus retinitis in a lung transplant patient - A case report",
abstract = "The purpose of this article is to report the use of valgancyclovir as maintenance therapy for cytomegalovirus (CMV) retinitis in a lung transplanted patient A 30-year-old woman with underlying pulmonary lymphangioleiomyomatosis received a lung transplant 1 year ago. CMV retinitis developed 4 months later but subsided after intravenous ganciclovir treatment. Unfortunately, the CMV retinitis recurred three times in 1 year while on oral ganciclovir maintenance therapy. To treat the latest relapse, valgancyclovir 900 mg once daily was used as maintenance therapy after intravenous gancyclovir induction. With a 6-month follow-up, the fundoscopic examination revealed old atrophic scar and no active CMV retinits. The patient was able to maintain best-corrected visual acuity of 20/20 in both eyes. In conclusion, Valganciclovir may be used as maintenance therapy in CMV retinitis.",
author = "Wang, {T. J.} and Lin, {C. P.} and Yang, {C. M.} and Lin, {L. L K}",
year = "2004",
month = "11",
doi = "10.1016/j.transproceed.2004.09.034",
language = "English",
volume = "36",
pages = "2826--2829",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - Valgancyclovir as maintenance therapy for cytomegalovirus retinitis in a lung transplant patient - A case report

AU - Wang, T. J.

AU - Lin, C. P.

AU - Yang, C. M.

AU - Lin, L. L K

PY - 2004/11

Y1 - 2004/11

N2 - The purpose of this article is to report the use of valgancyclovir as maintenance therapy for cytomegalovirus (CMV) retinitis in a lung transplanted patient A 30-year-old woman with underlying pulmonary lymphangioleiomyomatosis received a lung transplant 1 year ago. CMV retinitis developed 4 months later but subsided after intravenous ganciclovir treatment. Unfortunately, the CMV retinitis recurred three times in 1 year while on oral ganciclovir maintenance therapy. To treat the latest relapse, valgancyclovir 900 mg once daily was used as maintenance therapy after intravenous gancyclovir induction. With a 6-month follow-up, the fundoscopic examination revealed old atrophic scar and no active CMV retinits. The patient was able to maintain best-corrected visual acuity of 20/20 in both eyes. In conclusion, Valganciclovir may be used as maintenance therapy in CMV retinitis.

AB - The purpose of this article is to report the use of valgancyclovir as maintenance therapy for cytomegalovirus (CMV) retinitis in a lung transplanted patient A 30-year-old woman with underlying pulmonary lymphangioleiomyomatosis received a lung transplant 1 year ago. CMV retinitis developed 4 months later but subsided after intravenous ganciclovir treatment. Unfortunately, the CMV retinitis recurred three times in 1 year while on oral ganciclovir maintenance therapy. To treat the latest relapse, valgancyclovir 900 mg once daily was used as maintenance therapy after intravenous gancyclovir induction. With a 6-month follow-up, the fundoscopic examination revealed old atrophic scar and no active CMV retinits. The patient was able to maintain best-corrected visual acuity of 20/20 in both eyes. In conclusion, Valganciclovir may be used as maintenance therapy in CMV retinitis.

UR - http://www.scopus.com/inward/record.url?scp=11144283216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144283216&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2004.09.034

DO - 10.1016/j.transproceed.2004.09.034

M3 - Article

C2 - 15621160

AN - SCOPUS:11144283216

VL - 36

SP - 2826

EP - 2829

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 9

ER -